ID   PAN3_HUMAN              Reviewed;         887 AA.
AC   Q58A45; A0N0X1; A1A4Y8; A1A4Y9; B1ALF1; B7Z3W7; Q0D2P2; Q5HYG6; Q5T515;
AC   Q5T516; Q5TBA0; Q76E13; Q8NBA6;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   12-OCT-2022, entry version 149.
DE   RecName: Full=PAN2-PAN3 deadenylation complex subunit PAN3 {ECO:0000255|HAMAP-Rule:MF_03181};
DE   AltName: Full=PAB1P-dependent poly(A)-specific ribonuclease {ECO:0000255|HAMAP-Rule:MF_03181};
DE   AltName: Full=Poly(A)-nuclease deadenylation complex subunit 3 {ECO:0000255|HAMAP-Rule:MF_03181};
DE            Short=PAN deadenylation complex subunit 3 {ECO:0000255|HAMAP-Rule:MF_03181};
GN   Name=PAN3 {ECO:0000255|HAMAP-Rule:MF_03181};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 754-887 (ISOFORMS 1/2/3).
RC   TISSUE=Skin fibroblast;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 147-887 (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 147-887 (ISOFORMS 1 AND 3), FUNCTION,
RP   INTERACTION WITH PAN2 AND POLYADENYLATE-BINDING PROTEIN, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=14583602; DOI=10.1074/jbc.m309125200;
RA   Uchida N., Hoshino S., Katada T.;
RT   "Identification of a human cytoplasmic poly(A) nuclease complex stimulated
RT   by poly(A)-binding protein.";
RL   J. Biol. Chem. 279:1383-1391(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 654-887 (ISOFORMS 1/2/3).
RC   TISSUE=Adrenal gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   INTERACTION WITH PABPC1, AND MUTAGENESIS OF TYR-203 AND PHE-293.
RX   PubMed=18056425; DOI=10.1101/gad.1597707;
RA   Funakoshi Y., Doi Y., Hosoda N., Uchida N., Osawa M., Shimada I.,
RA   Tsujimoto M., Suzuki T., Katada T., Hoshino S.;
RT   "Mechanism of mRNA deadenylation: evidence for a molecular interplay
RT   between translation termination factor eRF3 and mRNA deadenylases.";
RL   Genes Dev. 21:3135-3148(2007).
RN   [8]
RP   INTERACTION WITH PABPC, AND MUTAGENESIS OF PHE-293.
RX   PubMed=17595167; DOI=10.1074/jbc.m701256200;
RA   Siddiqui N., Mangus D.A., Chang T.C., Palermino J.M., Shyu A.B.,
RA   Gehring K.;
RT   "Poly(A) nuclease interacts with the C-terminal domain of polyadenylate-
RT   binding protein domain from poly(A)-binding protein.";
RL   J. Biol. Chem. 282:25067-25075(2007).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18625844; DOI=10.1083/jcb.200801196;
RA   Zheng D., Ezzeddine N., Chen C.Y., Zhu W., He X., Shyu A.B.;
RT   "Deadenylation is prerequisite for P-body formation and mRNA decay in
RT   mammalian cells.";
RL   J. Cell Biol. 182:89-101(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   INTERACTION WITH TNRC6A; TNRC6B AND TNRC6C.
RX   PubMed=21981923; DOI=10.1016/j.molcel.2011.09.007;
RA   Braun J.E., Huntzinger E., Fauser M., Izaurralde E.;
RT   "GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA
RT   targets.";
RL   Mol. Cell 44:120-133(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-354, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   FUNCTION, SUBUNIT, INTERACTION WITH PAN2, AND ATP-BINDING.
RX   PubMed=23932717; DOI=10.1016/j.molcel.2013.07.011;
RA   Christie M., Boland A., Huntzinger E., Weichenrieder O., Izaurralde E.;
RT   "Structure of the PAN3 pseudokinase reveals the basis for interactions with
RT   the PAN2 deadenylase and the GW182 proteins.";
RL   Mol. Cell 51:360-373(2013).
CC   -!- FUNCTION: Regulatory subunit of the poly(A)-nuclease (PAN)
CC       deadenylation complex, one of two cytoplasmic mRNA deadenylases
CC       involved in general and miRNA-mediated mRNA turnover. PAN specifically
CC       shortens poly(A) tails of RNA and the activity is stimulated by
CC       poly(A)-binding protein (PABP). PAN deadenylation is followed by rapid
CC       degradation of the shortened mRNA tails by the CCR4-NOT complex.
CC       Deadenylated mRNAs are then degraded by two alternative mechanisms,
CC       namely exosome-mediated 3'-5' exonucleolytic degradation, or
CC       deadenlyation-dependent mRNA decaping and subsequent 5'-3'
CC       exonucleolytic degradation by XRN1. PAN3 acts as a positive regulator
CC       for PAN activity, recruiting the catalytic subunit PAN2 to mRNA via its
CC       interaction with RNA and PABP, and to miRNA targets via its interaction
CC       with GW182 family proteins. {ECO:0000255|HAMAP-Rule:MF_03181,
CC       ECO:0000269|PubMed:14583602, ECO:0000269|PubMed:23932717}.
CC   -!- SUBUNIT: Homodimer (PubMed:23932717). Forms a heterotrimer with a
CC       catalytic subunit PAN2 to form the poly(A)-nuclease (PAN) deadenylation
CC       complex (PubMed:14583602, PubMed:23932717). Interacts (via PAM-2 motif)
CC       with poly(A)-binding protein PABPC1 (via PABC domain), conferring
CC       substrate specificity of the enzyme complex (PubMed:17595167,
CC       PubMed:18056425). Interacts with the GW182 family proteins TNRC6A,
CC       TNRC6B and TNRC6 (PubMed:21981923). Interacts with YTHDF3 (By
CC       similarity). {ECO:0000255|HAMAP-Rule:MF_03181,
CC       ECO:0000269|PubMed:14583602, ECO:0000269|PubMed:17595167,
CC       ECO:0000269|PubMed:18056425, ECO:0000269|PubMed:21981923,
CC       ECO:0000269|PubMed:23932717}.
CC   -!- INTERACTION:
CC       Q58A45; P11940: PABPC1; NbExp=4; IntAct=EBI-2513054, EBI-81531;
CC       Q58A45; Q504Q3: PAN2; NbExp=6; IntAct=EBI-2513054, EBI-1058976;
CC       Q58A45; Q8NDV7: TNRC6A; NbExp=2; IntAct=EBI-2513054, EBI-2269715;
CC       Q58A45; Q9UPQ9: TNRC6B; NbExp=4; IntAct=EBI-2513054, EBI-947158;
CC       Q58A45; Q9HCJ0: TNRC6C; NbExp=4; IntAct=EBI-2513054, EBI-6507625;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000255|HAMAP-
CC       Rule:MF_03181, ECO:0000269|PubMed:14583602,
CC       ECO:0000269|PubMed:18625844}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Pan3b;
CC         IsoId=Q58A45-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q58A45-2; Sequence=VSP_023753, VSP_023755;
CC       Name=3;
CC         IsoId=Q58A45-3; Sequence=VSP_023754;
CC       Name=4;
CC         IsoId=Q58A45-4; Sequence=VSP_041648, VSP_041649;
CC   -!- DOMAIN: The N-terminal zinc finger binds to poly(A) RNA.
CC       {ECO:0000255|HAMAP-Rule:MF_03181}.
CC   -!- DOMAIN: Contains a pseudokinase domain. The protein kinase domain is
CC       predicted to be catalytically inactive because some of the residues
CC       important for catalytic activity are substituted and it lacks the
CC       equivalent of the binding site for a peptide substrate. However, it has
CC       retained an ATP-binding site and ATP-binding is required for mRNA
CC       degradation, stimulating the activity of the PAN2 nuclease in vitro.
CC       The nucleotide-binding site is juxtaposed to the RNase active site of
CC       PAN2 in the complex and may actually bind nucleosides of a poly(A) RNA
CC       rather than ATP, feeding the poly(A)-tail to the active site of the
CC       deadenylase and thus increasing the efficiency with which this
CC       distributive enzyme degrades oligo(A) RNAs. {ECO:0000255|HAMAP-
CC       Rule:MF_03181}.
CC   -!- DOMAIN: The pseudokinase domain, the coiled-coil (CC), and C-terminal
CC       knob domain (CK) form a structural unit (PKC) that forms an extensive
CC       high-affinity interaction surface for PAN2. {ECO:0000255|HAMAP-
CC       Rule:MF_03181, ECO:0000269|PubMed:14583602,
CC       ECO:0000269|PubMed:23932717}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. PAN3 family.
CC       {ECO:0000255|HAMAP-Rule:MF_03181}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI28180.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=ABK41888.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAC03632.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/pan3/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK091307; BAC03632.1; ALT_INIT; mRNA.
DR   EMBL; AK296435; BAH12353.1; -; mRNA.
DR   EMBL; EF088216; ABK41888.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL138712; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356915; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC024318; AAH24318.1; -; mRNA.
DR   EMBL; BC128179; AAI28180.1; ALT_INIT; mRNA.
DR   EMBL; BC128180; AAI28181.1; -; mRNA.
DR   EMBL; AB107584; BAD02262.1; -; mRNA.
DR   EMBL; AB109552; BAD93184.1; -; mRNA.
DR   EMBL; BX647740; CAI45987.2; -; mRNA.
DR   CCDS; CCDS9329.2; -. [Q58A45-1]
DR   RefSeq; NP_787050.6; NM_175854.7. [Q58A45-1]
DR   RefSeq; XP_005266390.1; XM_005266333.3. [Q58A45-3]
DR   RefSeq; XP_005266391.1; XM_005266334.1. [Q58A45-2]
DR   RefSeq; XP_016876021.1; XM_017020532.1. [Q58A45-2]
DR   RefSeq; XP_016876022.1; XM_017020533.1.
DR   AlphaFoldDB; Q58A45; -.
DR   SMR; Q58A45; -.
DR   BioGRID; 129129; 67.
DR   DIP; DIP-53755N; -.
DR   ELM; Q58A45; -.
DR   IntAct; Q58A45; 14.
DR   MINT; Q58A45; -.
DR   STRING; 9606.ENSP00000370345; -.
DR   ChEMBL; CHEMBL4105985; -.
DR   iPTMnet; Q58A45; -.
DR   PhosphoSitePlus; Q58A45; -.
DR   BioMuta; PAN3; -.
DR   DMDM; 341942213; -.
DR   EPD; Q58A45; -.
DR   jPOST; Q58A45; -.
DR   MassIVE; Q58A45; -.
DR   MaxQB; Q58A45; -.
DR   PaxDb; Q58A45; -.
DR   PeptideAtlas; Q58A45; -.
DR   PRIDE; Q58A45; -.
DR   ProteomicsDB; 62604; -. [Q58A45-1]
DR   ProteomicsDB; 62605; -. [Q58A45-2]
DR   ProteomicsDB; 62606; -. [Q58A45-3]
DR   ProteomicsDB; 62607; -. [Q58A45-4]
DR   Antibodypedia; 22704; 145 antibodies from 21 providers.
DR   DNASU; 255967; -.
DR   Ensembl; ENST00000380958.8; ENSP00000370345.3; ENSG00000152520.14. [Q58A45-1]
DR   GeneID; 255967; -.
DR   KEGG; hsa:255967; -.
DR   MANE-Select; ENST00000380958.8; ENSP00000370345.3; NM_175854.8; NP_787050.6.
DR   UCSC; uc001urz.4; human. [Q58A45-1]
DR   CTD; 255967; -.
DR   DisGeNET; 255967; -.
DR   GeneCards; PAN3; -.
DR   HGNC; HGNC:29991; PAN3.
DR   HPA; ENSG00000152520; Low tissue specificity.
DR   MIM; 617448; gene.
DR   neXtProt; NX_Q58A45; -.
DR   OpenTargets; ENSG00000152520; -.
DR   PharmGKB; PA144596398; -.
DR   VEuPathDB; HostDB:ENSG00000152520; -.
DR   eggNOG; KOG3741; Eukaryota.
DR   GeneTree; ENSGT00390000001504; -.
DR   InParanoid; Q58A45; -.
DR   OMA; AETMYSR; -.
DR   OrthoDB; 1515085at2759; -.
DR   PhylomeDB; Q58A45; -.
DR   TreeFam; TF105865; -.
DR   PathwayCommons; Q58A45; -.
DR   Reactome; R-HSA-429947; Deadenylation of mRNA.
DR   SignaLink; Q58A45; -.
DR   BioGRID-ORCS; 255967; 23 hits in 1077 CRISPR screens.
DR   ChiTaRS; PAN3; human.
DR   GenomeRNAi; 255967; -.
DR   Pharos; Q58A45; Tdark.
DR   PRO; PR:Q58A45; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q58A45; protein.
DR   Bgee; ENSG00000152520; Expressed in pancreatic ductal cell and 192 other tissues.
DR   ExpressionAtlas; Q58A45; baseline and differential.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0000932; C:P-body; IBA:GO_Central.
DR   GO; GO:0031251; C:PAN complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0008143; F:poly(A) binding; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; IBA:GO_Central.
DR   GO; GO:0010606; P:positive regulation of cytoplasmic mRNA processing body assembly; IEA:UniProtKB-UniRule.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IEA:GOC.
DR   HAMAP; MF_03181; PAN3; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR030844; PAN3.
DR   InterPro; IPR041332; Pan3_PK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR000571; Znf_CCCH.
DR   InterPro; IPR036855; Znf_CCCH_sf.
DR   PANTHER; PTHR12272; PTHR12272; 1.
DR   Pfam; PF18101; Pan3_PK; 1.
DR   SMART; SM00356; ZnF_C3H1; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF90229; SSF90229; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS50103; ZF_C3H1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Coiled coil; Cytoplasm; Metal-binding;
KW   mRNA processing; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..887
FT                   /note="PAN2-PAN3 deadenylation complex subunit PAN3"
FT                   /id="PRO_0000280525"
FT   ZN_FING         43..71
FT                   /note="C3H1-type"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03181"
FT   REGION          102..147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          284..307
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          325..392
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          463..750
FT                   /note="Pseudokinase domain"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03181"
FT   REGION          790..887
FT                   /note="Knob domain"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03181"
FT   COILED          751..789
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03181"
FT   MOTIF           284..299
FT                   /note="PABPC-interacting motif-2 (PAM-2)"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03181,
FT                   ECO:0000269|PubMed:17595167"
FT   COMPBIAS        356..392
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         521
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03181"
FT   BINDING         570..577
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03181"
FT   BINDING         644..645
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03181"
FT   MOD_RES         354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q640Q5"
FT   VAR_SEQ         1..332
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023753"
FT   VAR_SEQ         231..284
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14583602,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023754"
FT   VAR_SEQ         333
FT                   /note="P -> MKLTDSTKGWIVWAALDSSMR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023755"
FT   VAR_SEQ         684..687
FT                   /note="QADL -> VSKN (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041648"
FT   VAR_SEQ         688..887
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041649"
FT   MUTAGEN         203
FT                   /note="Y->A: Reduces interaction with polyadenylate-binding
FT                   protein."
FT                   /evidence="ECO:0000269|PubMed:18056425"
FT   MUTAGEN         293
FT                   /note="F->A: Reduces interaction with polyadenylate-binding
FT                   protein."
FT                   /evidence="ECO:0000269|PubMed:17595167,
FT                   ECO:0000269|PubMed:18056425"
FT   CONFLICT        229
FT                   /note="R -> Q (in Ref. 5; BAD02262)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        569
FT                   /note="Y -> H (in Ref. 4; AAI28181)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        793
FT                   /note="R -> G (in Ref. 1; BAC03632)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        856
FT                   /note="D -> G (in Ref. 5; BAD02262/BAD93184)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   887 AA;  95613 MW;  4883F859D2A642D2 CRC64;
     MNSGGGLPPP SAAASPSSSS LAAAVAVVAP PGVGGVPGGA AVGVKLKYCR YYAKDKTCFY
     GEECQFLHED PAAGAAPGLG LHSNSVPLAL AGAPVAGFPP GAVAGGGAGP PPGPKKPDLG
     DPGTGAAAGG GGSSGGLDGP RLAIPGMDGG ALTDTSLTDS YFSTSFIGVN GFGSPVETKY
     PLMQRMTNSS SSPSLLNDSA KPYSAHDPLT SPASSLFNDF GALNISQRRK PRKYRLGMLE
     ERLVPMGSKA RKAKNPIGCL ADRCKSGVPI NMVWWNRVTE NNLQTPNPTA SEFIPKGGST
     SRLSNVSQSN MSAFSQVFSH PSMGSPATAG LAPGMSLSAG SSPLHSPKIT PHTSPAPRRR
     SHTPNPASYM VPSSASTSVN NPVSQTPSSG QVIQKETVGG TTYFYTDTTP APLTGMVFPN
     YHIYPPTAPH VAYMQPKANA PSFFMADELR QELINRHLIT MAQIDQADMP AVPTEVDSYH
     SLFPLEPLPP PNRIQKSSNF GYITSCYKAV NSKDDLPYCL RRIHGFRLVN TKCMVLVDMW
     KKIQHSNIVT LREVFTTKAF AEPSLVFAYD FHAGGETMMS RHFNDPNADA YFTKRKWGQH
     EGPLPRQHAG LLPESLIWAY IVQLSSALRT IHTAGLACRV MDPTKILITG KTRLRVNCVG
     VFDVLTFDNS QNNNPLALMA QYQQADLISL GKVVLALACN SLAGIQRENL QKAMELVTIN
     YSSDLKNLIL YLLTDQNRMR SVNDIMPMIG ARFYTQLDAA QMRNDVIEED LAKEVQNGRL
     FRLLAKLGTI NERPEFQKDP TWSETGDRYL LKLFRDHLFH QVTEAGAPWI DLSHIISCLN
     KLDAGVPEKI SLISRDEKSV LVVTYSDLKR CFENTFQELI AAANGQL
//
